Manuel Bardies

Manuel Bardiès has been developing his research in radiopharmaceutical dosimetry within INSERM since 1991, in Nantes (20 years since 1991), in Toulouse (from 2011 to 2020) and now in Montpellier. He joined INSERM (French National Institute of Health and Medical Research) in 1992 as Research Scientist, and as Research Director since 2009.

Manuel Bardiès was one of the founders of the EANM Dosimetry Committee (member from 2001 to 2013, chair 2009-2011). He also chaired the EFOMP Science Committee between 2014 and 2016, and is currently chairing EFOMP new Special Interest Group for Radionuclide Internal Dosimetry.

Manuel Bardiès developed an increasing interest in education, within the European School of Multimodality Imaging & Therapy (ESMIT) and in the Board of the European School for Medical Physics Experts (ESMPE). He is the current chair of the Education Committee of the French Society of Medical Physics (SFPM ), and Vice-President of SFPM. He became Professor at the French Institut National des Sciences et Techniques du Nucléaire (http://www-instn.cea.fr) in 2018.

The group led by Manuel Bardiès in Montpellier is primarily involved in radiopharmaceutical dosimetry, at various scales (cell, tissue, organ). This requires the ability to assess radiopharmaceutical pharmacokinetics in vivo, through quantitative SPECT or PET imaging (clinical or small animal imagers). An important part of research activity is related to Monte Carlo modelling of radiation transport through biologic structures of interest, in order to give account of energy deposition within tumour targets – or critical non-tumour tissues/organs. The objective is to improve molecular radiotherapy by allowing patient-specific treatments (personalized medicine).